High-Intensity Focused Ultrasound for Essential Tremor

(MEG Trial)

This trial explores how High-Intensity Focused Ultrasound (HiFU) can assist individuals with essential tremor, a condition causing uncontrollable shaking, usually in the hands. The goal is to assess how this treatment affects brain networks using safe tests like brain scans and movement assessments. HiFU targets a specific brain area with sound waves to reduce tremors. Individuals whose essential tremor has not improved with at least two different medications might be suitable candidates for this trial.

As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could lead to new treatment options.

The trial information does not specify if you need to stop taking your current medications. However, since it mentions that participants should be refractory (not responding) to at least two first-line tremor medications, you might be expected to continue your current treatment.

Research has shown that High-Intensity Focused Ultrasound (HiFU) generally provides a safe treatment for essential tremor. Studies have found that most patients tolerate this treatment well. Side effects, such as difficulty walking steadily, are usually temporary. Most patients notice immediate improvement in their tremors and can return home the same day. Overall, HiFU offers an effective, non-surgical treatment option that has been successfully used for essential tremor and even tremors from Parkinson's disease.¹²³⁴⁵

High-Intensity Focused Ultrasound (HiFU) is unique because it offers a non-invasive approach to treating essential tremor, a condition often managed with medications like beta-blockers and anticonvulsants. Unlike these standard treatments, which can have systemic side effects and varying effectiveness, HiFU precisely targets and destroys the brain tissue causing the tremor without requiring surgery. Researchers are excited about HiFU because it provides a targeted treatment option that could lead to rapid symptom relief and improved quality of life for patients who don't respond to traditional medications.

Research has shown that High-Intensity Focused Ultrasound (HiFU), the treatment under study in this trial, effectively addresses essential tremor, a condition causing uncontrollable shaking. Studies have found that 33% of patients experience complete relief from tremors, while 47% see their tremors reduced by 50-99%. Overall, tremor improvement rates range from 50 to 75%, with benefits lasting up to five years. This treatment is generally well-tolerated, although some patients may temporarily have trouble walking. Overall, HiFU provides significant and lasting relief for many people with essential tremor.¹²³⁶⁷